Concord Medical to Present at the J.P. Morgan 29th Annual Healthcare Conference
BEIJING, Jan. 4, 2011 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it will present at the J.P. Morgan 29th Healthcare Conference to be held on January 10-13, 2011 at the Westin St. Francis Hotel in San Francisco.
Mr. Steve Sun, chief financial officer of Concord Medical, is scheduled to present from 9:30 a.m. to 10 a.m. on January 12, 2011 and will be available to meet with conference participants throughout the conference.
For more information regarding this conference, please contact your J.P. Morgan institutional sales representative or email [email protected].
About Concord Medical
Concord Medical operates the largest network of radiotherapy and diagnostic imaging centers in China in terms of revenues and the total number of centers in operation per available statistics. The Company currently operates a network of more than 111 centers spanning 41 cities and 23 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, the Company provides radiotherapy and diagnostic imaging equipments and manages the daily operations of these centers located on its hospital partners' premises. The Company also provides ongoing training to doctors and other medical personnel in its network of centers to ensure a high level of clinical care for patients.
Safe Harbor Statement
This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "project," "predict," "should" and "will" and similar expressions. These forward looking statements are based upon management's current views and expectations with respect to future events and are not a guarantee of future performance. Furthermore, these statements are, by their nature, subject to a number of risks and uncertainties that could cause actual performance and results to differ materially from those discussed in the forward-looking statements as a result of a number of factors. Such factors include: the number of new radiotherapy and diagnostic imaging centers opened; the increase in the number of patients in existing centers; the establishment of specialty cancer hospitals; changes in the healthcare industry in China, including changes in the healthcare policies and regulations of the PRC government; and technological or therapeutic changes affecting the field of cancer treatment and diagnostic imaging. Further information regarding these and other risks is included in the Company's filings with the U.S. Securities and Exchange Commission at www.sec.gov. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
Investor and Media Contacts |
|
China |
|
Tony Tian |
|
Concord Medical Services |
|
+86-10-5957-5287 |
|
Lilian Wong |
|
Brunswick Group, LLC |
|
+86-10-6566-2256 |
|
United States |
|
Nicki Kahner |
|
Brunswick Group, LLC |
|
+1-212-333-3810 |
|
SOURCE Concord Medical Services Holdings Limited
Share this article